Galapagos Awarded €2.9M IWT Grant for Cystic Fibrosis Research

By: Benzinga
Galapagos NV (OTC: GLPYY ) announced today that it has been awarded a €2.9 million grant from the Flemish agency for Innovation by Science and Technology (IWT) for cystic fibrosis (CF) research. The goal of this 3-year project is to identify and progress multiple promising CF therapies towards pre-clinical
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.